ClinicalTrials.Veeva

Menu

Axillary Versus Primary Breast Approach for Second-stage Breast Reconstruction (AvBSR)

Zhejiang University logo

Zhejiang University

Status

Not yet enrolling

Conditions

Breast Reconstruction
Breast Neoplasm Female
Wound Complication

Treatments

Procedure: implant exchange operation

Study type

Interventional

Funder types

Other

Identifiers

NCT05600153
IRB-2022- 1451

Details and patient eligibility

About

The goal of this clinical trial is to compare the safety of axillary or primary breast approach for second-stage operation in expander-implant breast reconstruction for breast cancer patients. The main question it aims to answer are: 1. if the wound related events, including wound dehiscence, infection, delayed healing is significant less often in patients receiving second stage operation via axillary approach compared with primary breast approach; 2. if the aesthetic outcome is comparable between patients receiving different approach for second stage operation. To answer these questions, the breast cancer patients have received nipple-sparing or skin-sparing mastectomy and had breast tissue expander insertion via breast incision, will be prospectively recruited, and randomized into two groups while receiving implant exchange operation: (1) operate via axillary incision; (2) operate via primary breast incision.

Enrollment

136 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 + (inclusive)
  • Female
  • Invasive breast cancer or ductal carcinoma in situ was confirmed by preoperative pathology
  • SSM/NSM (skin sparing/nipple and areola sparing mastectomy) combined with expander implantation has been performed within a year
  • An incision on the surface of the breast is used to place an expander in the first-stage surgery
  • There is no clinical or radiological evidence of distant metastasis
  • Expander removal combined with prosthesis implantation is planned
  • Able and willing to sign an informed consent

Exclusion criteria

  • The first SSM/NSM combined expander implantation was performed via axillary approach
  • Patients participate in other clinical trial, which could potentially affect their participation in this trial
  • Adjuvant radiotherapy was planned post-operation
  • Patient who is pregnant and lactating
  • The expander is not sufficiently expanded pre-surgery (does not reach more than 90% of its volume)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

136 participants in 2 patient groups, including a placebo group

primary breast approach
Placebo Comparator group
Treatment:
Procedure: implant exchange operation
axillary approach
Experimental group
Treatment:
Procedure: implant exchange operation

Trial contacts and locations

1

Loading...

Central trial contact

Chao NI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems